New Plasma Therapy Arrives in Los Angeles

Therapeutic Plasma Exchange (TPE) has traditionally been a hospital-based procedure used to treat a range of serious autoimmune and neurological disorders. The process involves separating plasma from blood cells to remove harmful antibodies or toxins, then returning the blood cells with a replacement fluid. This new application, developed by the medical technology company MDLifespan, adapts TPE for outpatient use specifically to combat modern environmental health issues. It differs from the conventional model by focusing on reducing the cumulative burden of circulating toxins and inflammatory proteins acquired from the environment. Los Angeles residents face distinct environmental threats, including exposure to particulate matter from urban air pollution and increasingly frequent wildfires. Research has linked these pollutants to a variety of health impacts, including respiratory conditions, cardiovascular effects, and immune system disruption. The treatment protocol begins with advanced diagnostics to measure an individual's specific toxin load and key inflammatory biomarkers. Progress is then monitored through objective laboratory data over a series of sessions, allowing for a personalized approach to reducing a patient's systemic inflammatory burden. This data-driven method aligns with the growing use of TPE in longevity and wellness medicine, where it is explored for its potential to improve biomarkers associated with aging. Some clinical trials have suggested that TPE can reduce biological age, as measured by multi-omic biomarkers, by improving proteins and inflammatory markers. The service is being launched through a clinical integration with Cenegenics Beverly Hills, a physician-led performance health center. This collaboration makes the specialized, multi-session protocol accessible in a non-hospital setting.